Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Abacus Insights is raising $28 Million in new funding. Sources indicate as part of senior management Chief Executive Officer, Minalkumar Patel played…
Allston, MA – According to filings with the U.S. Securities and Exchange Commission, Manifold Bio is raising $39,999,985.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Gleb Kuznetsov played a…
Allston, MA – According to filings with the U.S. Securities and Exchange Commission, Concerto Biosciences is raising $24,541,949.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Cheri Ackerman played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Atlantic Quantum is raising $9,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Bharath Kannan played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Abata Therapeutics is raising $95,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Samantha Singer…
Milford, MA – According to filings with the U.S. Securities and Exchange Commission, Reprieve Cardiovascular is raising $15,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Mark Pacyna played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Quaise Energy is raising $51,990,988.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Carlos Araque played a…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, PaymentWorks is raising $17,000,000.00 in new funding. Sources indicate as part of senior management President, Thayer Stewart played a key role in…
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, NFlection Therapeutics is raising $20,000,000.00 in new funding. Sources indicate as part of senior management President, William Hodder played a key role…
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Mytide Therapeutics is raising $7,067,713.00 in new funding. Sources indicate as part of senior management President, Dale Thomas played a key role…